Cargando…
Levetiracetam Monotherapy in Children with Epilepsy: A Systematic Review
BACKGROUND: Levetiracetam, a second-generation anti-epileptic drug (AED) with a good efficacy and safety profile, is licensed as monotherapy for adults and children older than 16 years with focal seizures with or without secondary generalization. However, it is increasingly being used off-label in y...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4469086/ https://www.ncbi.nlm.nih.gov/pubmed/26013703 http://dx.doi.org/10.1007/s40263-015-0248-9 |